CPDR is a program of the Uniformed Services University of the Health Sciences
and the Henry M. Jackson Foundation for the Advancement of Military Medicine

< Publications Archive

> 1998 Publications

1-10  21-24 

 

11. The contemporary value of pretreatment prostate acid phosphatase (PAP) to predict pathologic stage and recurrence in radical prostatectomy patients.
Moul JW, Connelly RR, Perahia B, McLeod DG:
J Urol, 159:935-40, 1998.

 

12. Perineal seeding of prostate cancer as the only evidence of recurrence 14 years after needle biopsy and radical prostatectomy molecular correlation.
Moul JW, Bauer JJ, Srivastava S, Colon E, Sesterhenn IA, Ho CK, McLeod DG:
Urology 51:158-60, 1998.

 

13. p53 protein and gene alterations in pathological stage C prostate carcinoma (letter).
Moul JW, Bauer JJ, Sesterhenn IA, Stackhouse GB, Srivastava:
J Urol, 159:1648-9, 1998.

 

14. Efficacy of multiple administration of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model.
Li Z, Rakkar A, Katayose Y, Kim M, Shanmugam N, Srivastava S, Moul JW, McLeod DG, Cowan KH, and Seth P:
Gene Therapy, 5:605-613, 1998.

 

15. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A. Sesterhenn IA, Mostofi FK, Moul JW:
Cancer, 83:1002-11, 1998.

 

16. Molecular analysis of p16 (Ink4)/CDKN2 and p15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A. Gaddipati JP, Moul JW, Srivastava S:
J Urol, 159:1725-30, 1998.

 

17. Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumors.
Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW:
Int. J Androl, 21:283-8, 1998.

 

18. Immunohistochemical and mutational analysis of the p53 tumor suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
Heidenreich A, Schenkman NS, Sesterhenn IA, Mostofi KF, Moul, JW, Srivastava S, Engelman, UH:
APMIS (Denmark), 106(1) 90-99, 1998.

 

19. Molecular analysis of p16Ink4/CDKN2 and p15Ink4B/MTS2 Genes in Primary Human Testicular Germ Cell Tumors.
Heidenreich A, Gaddipati JP, Moul JW, and Srivastava S:
J. Urol., 159:1725-1730, 1998.

 

20. A Long-term Study of the Efficacy of Treatment of Localized Prostate Cancer.
Friedrichs MD, Moul JW, Wojcik B, Donatucci C, Optenberg S, Kreder K, Thompson IM:
Urol Oncol., 1998.